Hackers stole Pfizer-BioNTech vaccine data in Europe, say firms
The Pfizer-BioNTech COVID-19 vaccine is among the top contenders in a global race to develop a successful inoculation. US drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to their development of a COVID-19 vaccine had been “unlawfully accessed” in a cyberattack on Europe’s medicines regulator. The European Medicines Agency (EMA), responsible for assessing and approving medicines and vaccines for the European Union (EU), said hours earlier that it had been targeted in a cyberattack. It gave no further details. Pfizer and BioNTech said they did not believe any personal data of trial participants had been compromised and EMA “has assured us that the cyberattack will have no impact on the timeline for its review.” It was not immediately clear when or how the attack took place, who was responsible or what other information may have been compromised. A spokeswoman for BioNTech declined further comment. Pfizer did not immediately respond to a request